Director of Vascular and Interventional Radiology & Vein Treatment Center
Director of Wound Healing Center
Mount Sinai Medical Center Miami Beach Florida USA
Robert s a board-certified vascular and interventional radiologist, joining the staff at Mount Sinai Medical Centre in 2006.
An expert in carotid artery stenting, he participated in a clinical trial that paved the way for Medicare to approve the treatment as a reimbursable procedure. He is also participating in the NIH-sponsored CREST-2 carotid stent trial. He has a robust vascular practice for the treatment of PVD, CLI and endovascular repair of Aortic Aneurysms and also specializes in uterine fibroid embolization and in the chemo embolization of inoperable liver tumors. In addition to being the Director of Vascular/Interventional Radiology, he is also Director of the Wound Healing Center.
He has participated in more than 75 clinical trials, has authored many publications in peer-reviewed medical journals, and presented his work at numerous regional, national, and international medical meetings, and is a member of a number of associations.
St. Antonius Hospital Netherlands
Jos’ main interest is in interventional and vascular radiology. He successfully defended his thesis entitled “Groin hernia: the role of diagnostic imaging” dealing with the role of Magnetic Resonance Imaging in the diagnosis of groin hernia in April 2001. Since July 2001 he has been the Head of the Department of Radiology of the St. Antonius Hospital and is also Head of the Service of Interventional Radiology in the Ospedale Regionale di Lugano, Switzerland, is Associate Professor of Radiology (Privat Dozent), as well as a lecturer in the Medical Faculty at the University of Bern. Jos is also Associate Professor of Vascular Surgery at the University of Pisa, Italy.
He is a past-president of the Dutch Endovascular Forum, is an active member of the Dutch Society of Radiology (Nederlandse Vereniging voor Radiologie), the ECR (European Congress of Radiology), CIRSE (Cardiovascular and Interventional Radiological Society of Europe) and the SSCVIR (Swiss Society of Cardiovascular and Interventional Radiology), and corresponding member of the SIR (Society of Interventional Radiology) and ESR (European Society of Radiology). Finally he is reviewer for the official journal of the ECR, European Radiology, as well as for the official journal of the SIR, the Journal of Vascular and Interventional Radiology (JVIR), reviewer of the official journal of the ISVS (VASCULAR), reviewer of the official journal of the Society of Vascular Surgery (Journal of Vascular Surgery), reviewer of the European Journal of Radiology, reviewer of the journal Vascular Disease Management, reviewer of the journal Annals of Vascular Surgery, reviewer and member of the Editorial Board of the Journal of Cardiovascular Surgery, and reviewer and member of the Editorial Board of the Journal of Endovascular Therapy.
Guys and St Thomas’ Hospital London
Stephen was a Consultant Vascular Surgeon and Honorary Senior Lecturer at St George’s Vascular Institute, St George’s Hospital, London from 2010 until 2014. He also held an Honorary Consultant post at Epsom and St Helier University Hospitals NHS Trust during this time. While at St Georges, in addition to offering a full vascular practice, he established and led the Deep Venous Reconstruction service offering intervention for patients with acute and chronic DVT. This quickly grew to become one of the largest such practices in Europe. In 2014 he was approached by St Thomas’ hospital to move and run their Deep Venous and Lymphoedema service.
Stephen specialises exclusively in vascular surgery and has interests in both arterial and venous disease. This includes cover of aneurysmal disease (including endovascular techniques), carotid surgery for the treatment of stroke, treatment of diabetic vascular complications and peripheral vascular disease.
His venous practice is well established and he has a particular interest in this field and is the lead for deep venous surgery at St Thomas’ Hospital. He is on the program committee for the European Venous Forum Hands on Workshops (EVF HOW) and the annual Charing Cross Vascular Symposium – one of the largest vascular meetings in the world. He has lectured widely on the subjects of treatment of acute and chronic DVT, has an interest in training and ongoing medical research. He is an examiner for the Fellowship of the European Board of Vascular Surgery.
University of Heidelberg Germany
Dittmar has since 2007 been an Associate Professor of Surgery at the University of Heidelberg and, in 2011 was made the Chairman of the Department of Vascular and Endovascular Surgery. He has published widely.
University Hospital Leipzig Germany
Sven has been working with Dierk Scheinert since 2002. His focus is on state-of-the-art interventional therapy of all kinds of PAOD, especially lower extremeties, CTO’s, CLI and BTK in a high volume centre with more than 4000 interventions per year. His other interest is on all modalities of aortic repair, carotid artery stenting, renal artery stenting and denervation, as well as novel treatment options like drug eluting technology and atherectomy.
He has been a co-organiser of LINC, which now sees 5000 attending from more than 80 countries, and is a member of the faculty and co-organiser of LAP – LINC Asia-Pacific in Hong Kong. He is a live case operator and faculty at leading medical conferences, including LINC, LINC Asia-Pacific, VERVE, VIVA, TCT, NCVH, Cirse, and Charing Cross.
Medical University, Graz Austria
Marianne is attached to the Division of Angiology, Department of Internal Medicine at the Medical University, Graz Austria.
Since 2013 she has been a member of the nucleus of the European Society of Vascular Medicine, is a longstanding member of the UEMS Board of Angiology and was President of the ÖGIA (Austrian Society of Angiology) from 2012 to 2014. Her research interests include anticoagulation and thrombolysis; new endovascular technologies in the peripheral field; and evaluation of nature of restenosis and has participated in 50 international clinical trials. She was President of the Working Group Peripheral Circulation of the European Society of Cardiology from 2014 to 2016.
Clinique Chirurgicale Val d’Or, Saint Cloud Paris France
Jacques is currently coordinator of vascular and endovascular service in the Cardiovascular Department of the Clinique Chirurgicale Val d’Or – Saint Cloud, in Paris, France, part of the Vivalto Foundation Group.
In 1988, he set up one of the first endovascular programs in France using peripheral angioplasty and stents, after several post-residency trainings in USA (Los Angeles, Phoenix, New Orleans). Since this time, he is actively involved as speaker, moderator and scientific committee member of the major international vascular and endovascular meetings (Arizona Heart, Charing Cross, CEC, CICE , CIT, EuroPCR, Ochsner, Mayo, SITE, TCT, VEITH, VERVE, VIVA).
Jacques is a former board member of the French Society of Vascular Surgery and serves as an editorial board member in the Journal of Endovascular Therapy (USA), the Endovascular Today Magazine (USA), the Endovascular Today Magazine – Europe (USA) and Tecnicas Endovasculares (Spain).
In November 2010, he received the international vascular award “Pionner in Performance” in New York City during the Veith Symposium.
He is the co-founder of the International Council of the International Society of Endovascular Specialists (ISES), as well a past executive board member and former chairman and president, and is now an ISES International Ambassador. This Society has 1600 members and is represented in 60 countries. He also serves as President of the Val d’Or Vascular Association, a French non-profit organization dedicated to research and development in cardiovascular medicine. Since 2006, under its auspices, he runs annually in Paris a successful vascular meeting on vascular diseases, cardio-vascular imaging and endovascular technologies open to cardio-vascular specialists.
MedStar Union Memorial Hospital in Baltimore, Maryland USA.
Frank is widely recognised to be a pioneer in endovascular therapy, and a major presence at most major vascular and endovascular congresses and events in the U.S. and around the world. He has contributed extensively to the literature with more than 170 papers, editorials, and book chapters. He was the Editor-in-Chief of Vascular Disease Management (VDM) from its inception in 2004 until the end of 2013. He has also been very active in clinical research, with a major focus on aortic stent-graft and carotid interventions, and endovascular technologies in general. He was the U.S. National Principal Investigator (P.I.) for the Medtronic Talent AAA clinical trials, and a member of the Executive Committee for the Medtronic Valor and Valor II Thoracic TAA trials. Additionally, he has been a Site-Principal Investigator for multiple other clinical studies testing aortic endografts and carotid-stent systems.
Assoc Prof Brian DeRubertis UCLA Medical Centre Los Angeles USA
Following his vascular and endovascular surgery fellowship with the Division of Vascular Surgery of Cornell University and Columbia College of Physicians and Surgeons at New York Presbyterian Hospital, Brian joined the Division of Vascular Surgery at the David Geffen School of Medicine at UCLA in 2007, and is an attending surgeon at the UCLA Ronald Regan Medical Center and at the UCLA-Santa Monica Medical Center. His current surgical practice involves the application of the newest minimally invasive technology for the treatment of complex aortic aneurysms, peripheral arterial disease of the carotid arteries and lower extremities, and venous disorders including deep venous thrombosis, Paget-Schroetter’s Syndrome, and May-Thurner’s Syndrome. He has a particular interest in innovative device technology, and has introduced the practice of percutaneous EVAR and the use of fenestrated aortic endografts to his institution.
He is very active in clinical research on these topics and has presented widely at US and International Conferences. He has also co-authored 13 book chapters and more than 65 peer-reviewed publications in journals that include Surgery, the Journal of Vascular Surgery, Vascular and Endovascular Surgery, Archives of Surgery, Cancer Gene Therapy, and many others.
He is a national Co-Prinicipal investigator on the REALITY Trial, which evaluates the utility of atherectomy and drug-coated balloon angioplasty as a treatment for femoropopliteal disease in claudicants, and has participated in over a dozen clinical trials at UCLA, including the current NIH-funded BEST-CLI Trial for lower extremity revascularization. He is an active member of multiple surgical societies, including the Society for Vascular Surgery, the Western Vascular Society, the Pacific Coast Surgical Society, and the Vascular and Endovascular Surgery Society, among others, and has served as Co-Director of the Peripheral Vascular Course at the annual Transcatheter Therapeutics Conference.
Director of Vascular and Interventional Radiology Department – “Careggi” University hospital – Florence
Fabrizio is a professor of radiology at “Sapienza” University of Rome and is involved in the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) as a member of the Executive Committee, and the current chair of the CIRSE program committee. He is also a member of the program committee of GEST Europe and PCR peripheral.
He is treasurer of the UEMS (European Union of Medical Specialty) Interventional Radiology Division and is a member of the “EBIR Council” (European Board of Interventional Radiology). He is involved in several experimental studies for the evaluation of new materials and devices in clinical practice.
Fabrizio has authored and co-authored numerous papers concerning the radiological, surgical and clinical fields, authored three books and co-authored sixteen books, a reviewer for several scientific journals and part of the editorial board of “Cardiovascular and Interventional Radiology “, Section Editor of EURORAD – Vascular and Interventional Radiology – ESR European Society of Radiology, and an editorial board member of “ESIR on-line” (European School of Interventional Radiology – CIRSE) and “ESR e-learning” (European Society of Radiology).
Service de Chirurgie Vasculaire, Hopital Nord Laennec, Nantes France
Yann is the Professor and Chief of the Department of Vascular Surgery Service de Chirurgie Vasculaire, Hopital Nord Laennec, Nantes France. Since Sept 2007, he has also been the Senior University Lecturer and Hospital Practitioner in the Vascular Surgery Department at the University Hospital of Nantes.
He has extensive clinical studies experience, continues his research interests and has published widely.
ZNA part of the Hospital Network of Antwerp Belgium
He is a vascular and endovascular surgeon, senior staff member of the Vascular Clinic ZNA, part of the Hospital Network of Antwerp, Belgium, as well as Co-director of the ZNA Multi-Disclipinary Diabetic Foot Clinic and of the ZNA Chronic Wound Clinic. He also coordinates the surgical training program and vascular fellowship in the hospital.
His special interests besides endovascular treatment are diabetic foot problems, vascular access surgery and the development and amelioration of new technologies and techniques.
Peter has been involved in research, education and clinical assessment related to new medical devices and new approaches in the endovascular field. He developed new techniques for the treatment of aortoiliac (i.e. CERAB & Chimney-CERAB) and femoropoliteal occlusive disease, and is taking part in a number of national and international organised studies and is a member of numerous national and international vascular and interventional societies.
University of Beijing General Hospital Beijing China
Wei is also associated with the Nankai University Tianging China. He is the Secretary of the Chinese Vascular Surgical Society and Vice President of the China Vascular Surgeons Association and Chairman of the China Endovascular Course (CEC). He began the endovascular device research, as well as the endovascular aneurysm repair and peripheral vessel disease intervention.
He has over 3500 EVAR and TEVAR experience and has participated in ENGAGE trial and organised more than 20 clinical trials during the past 5 years. He has edited 10 books, 16 book chapters and 143 scientific papers.
Kansai Rosai Hospital Cardiovascular Center Japan
Osau is an interventional cardiologist. His area of interest is coronary and peripheral artery disease.
He has published widely and authored numerous articles.
Harvard Medical School and Massachusetts General Hospital, Boston USA
Michael is Professor of Medicine at Harvard Medical School, Chair of the MGH Institute for Heart, Vascular, and Stroke Care, Medical Director of the Vascular Center, and the Medical Director of the Vascular Diagnostic Laboratory at the Massachusetts General Hospital.
In January 2014, he was named the first incumbent of the Paul and Phyllis Fireman Endowed Chair in Vascular Medicine at the Massachusetts General Hospital.
He is an active clinical consultant in all aspects of vascular medicine, including peripheral arterial disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine. He is Founder and Medical Director of the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States; is the Past-President of the Society for Vascular Medicine and Biology, and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He has an Honorary Doctorate of Science from the A.T Still University School of Medicine and is a recipient of the “Leaders in Vascular Education” Award.
AZ Sint-Blasium Dendermonde Belgium
Koen is a vascular surgeon and currently Medical Director of the Diabetic Wound Clinic and Assistant Director of the Department of Surgery and Vascular Surgery at AZ Sint-Blasium Dendermonde Belgium.
As an active researcher, Dr Deloose has authored and co-authored more than 60 peer reviewed medical journals, contributed to more than 10 chapters in orthopaedic, vascular, and endovascular books as well as many posters and papers in conference proceedings. He is a member of the International Editorial Board, Endovascular Section of the Journal of Cardiovascular Surgery and Editorial Advisory Board Member of Endovascular Today. He is also a teacher and proctor for several medical device companies in-hospital and in his co-owned animal lab in Belgium. He is a member of many committees and boards including the Royal Belgian Society of Surgery and Treasurer of the Belgian Society of Vascular Surgery. He is founding President of the Belgium Young Flownmasters, a Belgian working for young and ambitious vascular surgeons.
University of Wisconsin School of Medicine and Public Health USA
Jon is a practicing vascular surgeon and the Chair of the Division of Vascular Surgery at University of Wisconsin School of Medicine and Public Health. He is board certified in Surgery with added qualifications in Vascular Surgery.
His clinical interests are centered on endovascular treatment of all aspects of peripheral vascular disease, including carotid stenosis, thoracic aortic disease, lower extremity ischemia, deep venous thrombosis, and abdominal aortic aneurysm.
His research interests are concentrated on clinical trials of medical treatment and endovascular treatment of carotid stenosis and aortic aneurysm.
He is involved in the educational curriculum of medical students, residents, and fellows, and organizes several educational programs each year. He is involved in endovascular training of physicians from more than a hundred hospitals around the world.
He is widely published with over 95 peer-reviewed articles, 35 chapters, and 10 books.
Deaconess Hospital Flensburg – Academic Hospital of Kiel University Germany
Stefan is Professor of Radiology and Head of the Department of Diagnostic and Interventional Radiology / Neuroradiology at the Deaconess Hospital Flensburg – Academic Hospital of Kiel University, Faculty of Medicine, Germany.
He is a board certified Radiologist and Neuroadiologist active in endovasclular therapy for almost 20 years covering the whole spectrum of vascular and non-vascular interventional therapy. He is a passionate clinical researcher as PI, Co-PI and investigator in numerous clinical trials. Live-case transmissions, national and international workshops held in Flensburg as well as may lectures, publications, book-chapters and book project on complications in interventional therapy complete the spectrum.
Stefan received several awards, holds membership in several editorial boards and is responsible for on-line education as the current program director of ESIR-online and member of the CIRSE executive committee. His special interest is in endovascular drug therapy (DCB, DES), carotid disease and stroke management.
Metro Health Hospital Wyoming Michigan USA
Jihad Mustapha is a board-certified interventional cardiologist. He specializes in minimally invasive, non-surgical therapy for heart and peripheral vascular disease. He has advanced training in coronary stent and complex peripheral vascular disease treatments including laser, atherectomy, and totally occluded arteries. He is the Director of Cardiovascular Catheterization Laboratories, Director of Endovascular Interventions and Director of Cardiovascular Research at Metro Health Hospital – Metro Heart and Vascular in Wyoming Michigan. He is the Founder and Director of the AMPutation Prevention Symposium (AMP), has multiple publications, including those on critical limb ischemia and amputation prevention.
CH Galway Ireland
Gerry is an interventional radiologist – 70% of his practice would be in interventional radiology. He has been involved with a number of medical start-ups in the Galway area.
He is been interested in venous disease for a number of years and says he is still learning. He concentrates exclusively on IIio-femoral deep vein thrombosis and reconstruction.
North Carolina Heart & Vascular
University of North Carolina Health Care Raleigh, NC
Ravish Sachar, MD, earned his medical degree from the University of Southern California School of Medicine, Los Angeles, and completed an internal medicine residency at Columbia-Presbyterian Medical Center, New York, NY. He then completed fellowships in cardiovascular medicine and interventional cardiology at Cleveland Clinic, OH.
An active clinical researcher, Dr Sachar is widely published, including 2 textbooks and several book chapters on peripheral vascular intervention. He has been an invited lecturer at more than 30 regional, national, and international conferences and symposia, including Transcatheter Cardiovascular Therapeutics (TCT) and Complex Cardiovascular Catheter Therapeutics (C3). He frequently serves as course director or faculty for continuing medical education courses.
Dr Sachar is the founder and CEO of Contego Medical LLC, a company that has developed and is commercializing a family of novel devices that couple angioplasty with embolic protection. He has a passion for healthcare innovation and serves as Co-Managing Director of Rex Health Ventures, a hospital-based venture capital fund. He is a fellow of the American College of Cardiology and a member of the Society for Cardiac Angiography & Interventions.
Kaiser Foundation Hospital in Honolulu, Hawaii
Peter practices in Honolulu and has a strong interest in education and training in vascular and endovascular techniques. He has been in practice for 23 years and is Chief of Vascular Therapy at Kaiser Foundation Hospital in Honolulu and has worked with many residents and fellows. He attended Johns Hopkins School of Medicine and then University of California San Francisco for general and vascular surgery training.
He has served on many committees for the Society for Vascular Surgery and the Western Vascular Society, been invited to many visiting professorships, and served as Faculty or Course Director for specialty courses. He authored Endovascular Skills, now in its 3rd edition, and co-authored two other vascular books.
He is currently President of the Western Vascular Society and VIVA. Roles within the Kaiser organization have included Board of Directors and Chief Financial Officer.
Department of Surgery, University of Washington USA
Benjamin is a Professor of Vascular Surgery, Chief of the Division of Vascular Surgery and Vice Chair of the Department of Surgery for UW Medicine. Prior to this, he He is recognized nationally and internationally for his work in aortic pathology and vascular trauma, most notably the management of ruptured abdominal aortic aneurysms and acute aortic syndromes.
His current research activities focus on multi-branch and fenestrated endografting for complex aortic disease, vascular trauma and studying factors that influence outcomes for patients presenting with ruptured abdominal aortic aneurysm. He currently serves as Principal Investigator on ten clinical trials and as Associate Investigator on an additional twenty-two clinical trials.
In addition to clinical and research activities, Benjamin is highly involved in the academic community of vascular surgery. He has been author or co-author of over eighty peer-reviewed publications with a quarter as first author and written five book chapters. He is associated with a number of editorial review committees with leading international journals including The Journal of Vascular Surgery, Circulation, New England Journal of Medicine and Lancet. He is an active member of Western Vascular Society, Western Surgical Association and the Society for Vascular Surgery and current President of the Pacific Northwest Vascular Surgery Society. In addition he served as an Associate Examiner of the American Board of Surgery Vascular Surgery Certifying Examination in 2012 and as an Examiner in 2014. He travels widely presenting regularly at medical conferences around the globe.
Endologix Inc USA
Matt is Chief Medical Officer for Endologix Inc. Previously he was the Professor of Vascular Surgery at St George’s, University of London and a Consultant Vascular Surgeon at St Georges Vascular Institute (SGVI).
He trained at Cambridge, St Bartholomew’s Hospital, the University of Leicester and Adelaide. His awards include a Hunterian Professorship, the Moynihan travelling fellowship and the gold medal for the intercollegiate examination. His named lectures include the Kinmonth Lecture (Vascular Society Great Britain and Ireland), the British Journal of Surgery Lecture (Vascular Society Great Britain and Ireland), and the Chee Song Memorial Lecture (British Society of Endovascular Therapy).
His clinical interests are in the treatment of aortic disease and endovascular surgery. Professor Thompson is the editor of the Oxford Textbook of Vascular Surgery and the Oxford Handbook of Vascular Surgery.
Paracelsus Medical University Nuremberg, Germany
Eric completed his fellowship in Vascular Surgery at the University Medical Cente Groningen and accepted a position as Consultant Vascular Surgeon one year later. He set up an endovascular program in cooperation with the surrounding peripheral hospitals.
In 2005, he completed his PhD entitled “Endovascular Aneurysm Repair: Results and exploration of new frontiers” at the University of Groningen and in 2009 accepted a position as Chief of the Department of Vascular and Endovascular Surgery in Nuremberg Germany.
In January 2011, he was awarded a guest-professorship of Surgery at the University of Lisbon, Portugal, and in October 2011, he accepted a Professorship in Vascular Surgery at the University of Leuven, Belgium. In 2014, he became full professor in vascular surgery at the Paracelsus Medical University of Nuremberg.
His main interest, both clinical and scientific, continues to be the treatment of complex aortic aneurysms with fenestrated and branched grafts, with now experience in more than 1000 cases.
He presented results of his work in numerous congresses with more than 850 official presentations, and has published over 300 articles and book chapters.